GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Veritas In Silico Inc (TSE:130A) » Definitions » YoY EBITDA Growth

Veritas In Silico (TSE:130A) YoY EBITDA Growth : 0.00% (As of Dec. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Veritas In Silico YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Veritas In Silico's YoY EBITDA Growth for the quarter that ended in Dec. 2024 was 0.00%.

Veritas In Silico's EBITDA per Share for the three months ended in Dec. 2024 was 円0.00.


Veritas In Silico YoY EBITDA Growth Historical Data

The historical data trend for Veritas In Silico's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Veritas In Silico YoY EBITDA Growth Chart

Veritas In Silico Annual Data
Trend Dec21 Dec22 Dec23 Dec24
YoY EBITDA Growth
- 43.08 159.74 -363.69

Veritas In Silico Quarterly Data
Dec21 Dec22 Sep23 Dec23 Mar24 Jun24 Dec24
YoY EBITDA Growth Get a 7-Day Free Trial - - - - -

Veritas In Silico YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Veritas In Silico's YoY EBITDA Growth for the fiscal year that ended in Dec. 2024 is calculated as:

YoY EBITDA Growth (A: Dec. 2024 )
=(EBITDA per Share (A: Dec. 2024 )-EBITDA per Share (A: Dec. 2023 ))/ | EBITDA per Share (A: Dec. 2023 ) |
=(-30.949-11.737)/ | 11.737 |
=-363.69 %

Veritas In Silico's YoY EBITDA Growth for the quarter that ended in Dec. 2024 is calculated as:

YoY EBITDA Growth (Q: Dec. 2024 )
=(EBITDA per Share (Q: Dec. 2024 )-EBITDA per Share (Q: Sep. 2023 )) / | EBITDA per Share (Q: Sep. 2023 )) |
=(0-0)/ | 0 |
=N/A %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Veritas In Silico YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Veritas In Silico's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.


Veritas In Silico Business Description

Traded in Other Exchanges
N/A
Address
1-11-1, Nishigotanda, Shinagawa-ku, Tokyo, JPN, 141-0031
Veritas In Silico Inc is engaged in discovery of mRNA-targeted small molecule and antisense oligonucleotide drugs. It has ibVIS platform that combines informatics (i) and experimental biology at Veritas In Silico (VIS) that will bring to fruition mRNA-targeted drugs.

Veritas In Silico Headlines

No Headlines